Accelerate Diagnostics PE Ratio 2010-2024 | AXDXQ
Current and historical p/e ratio for Accelerate Diagnostics (AXDXQ) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Accelerate Diagnostics PE ratio as of June 26, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Accelerate Diagnostics PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-25 | 0.01 | 0.00 | |
| 2024-12-31 | 1.20 | $-2.34 | 0.00 |
| 2024-09-30 | 1.71 | $-2.86 | 0.00 |
| 2024-06-30 | 1.17 | $-2.21 | 0.00 |
| 2024-03-31 | 0.99 | $-4.07 | 0.00 |
| 2023-12-31 | 3.92 | $-4.89 | 0.00 |
| 2023-09-30 | 5.75 | $-5.40 | 0.00 |
| 2023-06-30 | 8.10 | $-7.26 | 0.00 |
| 2023-03-31 | 7.00 | $-7.20 | 0.00 |
| 2022-12-31 | 7.10 | $-7.60 | 0.00 |
| 2022-09-30 | 15.20 | $-9.60 | 0.00 |
| 2022-06-30 | 9.90 | $-9.30 | 0.00 |
| 2022-03-31 | 14.40 | $-10.60 | 0.00 |
| 2021-12-31 | 52.20 | $-12.60 | 0.00 |
| 2021-09-30 | 58.30 | $-12.50 | 0.00 |
| 2021-06-30 | 80.60 | $-14.30 | 0.00 |
| 2021-03-31 | 83.20 | $-14.20 | 0.00 |
| 2020-12-31 | 75.80 | $-14.00 | 0.00 |
| 2020-09-30 | 106.60 | $-14.60 | 0.00 |
| 2020-06-30 | 151.60 | $-15.00 | 0.00 |
| 2020-03-31 | 83.30 | $-15.30 | 0.00 |
| 2019-12-31 | 169.00 | $-15.40 | 0.00 |
| 2019-09-30 | 185.70 | $-15.60 | 0.00 |
| 2019-06-30 | 228.80 | $-16.00 | 0.00 |
| 2019-03-31 | 210.20 | $-16.50 | 0.00 |
| 2018-12-31 | 115.00 | $-16.20 | 0.00 |
| 2018-09-30 | 229.50 | $-14.80 | 0.00 |
| 2018-06-30 | 223.00 | $-13.80 | 0.00 |
| 2018-03-31 | 228.50 | $-12.60 | 0.00 |
| 2017-12-31 | 262.00 | $-11.60 | 0.00 |
| 2017-09-30 | 224.50 | $-12.00 | 0.00 |
| 2017-06-30 | 273.50 | $-12.30 | 0.00 |
| 2017-03-31 | 242.00 | $-12.70 | 0.00 |
| 2016-12-31 | 207.50 | $-12.90 | 0.00 |
| 2016-09-30 | 272.60 | $-12.70 | 0.00 |
| 2016-06-30 | 143.90 | $-11.80 | 0.00 |
| 2016-03-31 | 143.70 | $-11.00 | 0.00 |
| 2015-12-31 | 214.90 | $-10.10 | 0.00 |
| 2015-09-30 | 161.80 | $-9.20 | 0.00 |
| 2015-06-30 | 258.10 | $-8.70 | 0.00 |
| 2015-03-31 | 225.00 | $-7.90 | 0.00 |
| 2014-12-31 | 191.90 | $-7.10 | 0.00 |
| 2014-09-30 | 214.80 | $-6.40 | 0.00 |
| 2014-06-30 | 260.00 | $-5.40 | 0.00 |
| 2014-03-31 | 218.10 | $-4.80 | 0.00 |
| 2013-12-31 | 122.00 | $-4.50 | 0.00 |
| 2013-09-30 | 134.10 | $-3.20 | 0.00 |
| 2013-06-30 | 81.20 | $-2.20 | 0.00 |
| 2013-03-31 | 72.70 | $-1.60 | 0.00 |
| 2012-12-31 | 40.30 | $-0.70 | 0.00 |
| 2012-10-31 | 36.00 | $-4.00 | 0.00 |
| 2012-09-30 | 33.30 | $-4.00 | 0.00 |
| 2012-07-31 | 32.70 | $-3.60 | 0.00 |
| 2012-06-30 | 26.90 | $-3.60 | 0.00 |
| 2012-04-30 | 27.30 | $-0.30 | 0.00 |
| 2012-03-31 | 10.50 | $-0.30 | 0.00 |
| 2012-01-31 | 12.80 | 0 | 0.00 |
| 2011-10-31 | 28.70 | 0 | 0.00 |
| 2011-07-31 | 38.90 | 0 | 0.00 |
| 2011-04-30 | 38.60 | 0 | 0.00 |
| 2011-01-31 | 13.00 | 0 | 0.00 |
| 2010-10-31 | 11.00 | 0 | 0.00 |
| 2010-07-31 | 8.70 | 0 | 0.00 |
| 2010-04-30 | 8.30 | 0 | 0.00 |
| 2010-01-31 | 6.80 | 0 | 0.00 |
| 2009-10-31 | 12.80 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $0.012B |
| Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $186.962B | 81.89 |
| Thermo Fisher Scientific (TMO) | United States | $155.018B | 18.75 |
| Edwards Lifesciences (EW) | United States | $45.151B | 29.60 |
| Alcon (ALC) | Switzerland | $43.193B | 29.19 |
| IDEXX Laboratories (IDXX) | United States | $42.656B | 49.02 |
| DexCom (DXCM) | United States | $33.204B | 51.32 |
| IQVIA Holdings (IQV) | United States | $27.457B | 15.38 |
| Mettler-Toledo (MTD) | United States | $24.791B | 29.48 |
| STERIS (STE) | Ireland | $23.645B | 26.04 |
| Waters (WAT) | United States | $20.829B | 29.39 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.814B | 0.00 |
| Hologic (HOLX) | United States | $14.322B | 15.56 |
| Sysmex ADR (SSMXY) | Japan | $10.695B | 30.34 |
| Penumbra (PEN) | United States | $9.806B | 76.97 |
| Masimo (MASI) | United States | $9.179B | 33.86 |
| Globus Medical (GMED) | United States | $7.878B | 18.77 |
| Glaukos (GKOS) | United States | $5.675B | 0.00 |
| Teleflex (TFX) | United States | $5.265B | 8.69 |
| TransMedics (TMDX) | United States | $4.349B | 94.54 |
| Integer Holdings (ITGR) | United States | $4.215B | 22.08 |
| PROCEPT BioRobotics (PRCT) | United States | $3.221B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.501B | 14.89 |
| Nihon Kohden (NHNKY) | Japan | $2.156B | 24.73 |
| Veracyte (VCYT) | United States | $2.071B | 29.07 |
| Elekta AB (EKTAY) | Sweden | $1.965B | 17.67 |
| Alphatec Holdings (ATEC) | United States | $1.643B | 0.00 |
| Artivion (AORT) | United States | $1.307B | 122.40 |
| Tandem Diabetes Care (TNDM) | United States | $1.294B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.030B | 0.00 |
| OPKO Health (OPK) | United States | $1.007B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.922B | 4.91 |
| IRadimed (IRMD) | United States | $0.768B | 38.97 |
| SiBone (SIBN) | United States | $0.764B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.640B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.567B | 8.83 |
| RxSight (RXST) | United States | $0.536B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.535B | 12.53 |
| OrthoPediatrics (KIDS) | United States | $0.524B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.485B | 0.00 |
| AxoGen (AXGN) | United States | $0.467B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.458B | 12.18 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.426B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.415B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.375B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.366B | 0.00 |
| NeuroPace (NPCE) | United States | $0.347B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.329B | 0.00 |
| 908 Devices (MASS) | United States | $0.243B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.240B | 14.53 |
| Neuronetics (STIM) | United States | $0.225B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.221B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.218B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Inogen (INGN) | United States | $0.191B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.168B | 0.00 |
| CVRx (CVRX) | United States | $0.152B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.150B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.143B | 0.00 |
| Accuray (ARAY) | United States | $0.138B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.126B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.111B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.089B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.00 |
| EnVVeno Medical (NVNO) | United States | $0.074B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.044B | 0.00 | |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.85 |